• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • English
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

Hide Search
Shopping Cart
Show SearchSearch
866.626.6847
  • About
    • Our Work
    • Our Team
    • Our Partners
  • Exposures
    • Pregnancy and Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
  • Studies
    • Ongoing Studies
    • What’s Involved?
    • Join Now
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Meetings
    • FAQs
    • OTIS Membership
  • Media
    • Media Requests
    • Press Releases
    • eNews Sign Up
  • In Your Area
  • OTIS
    • About OTIS
    • OTIS Membership
    • Annual Meeting
    • Member Log-In
    • Donate
  • Contact
  • Show SearchSearch

Allergy & Immunology

Make Informed Decisions for Treating Patients with Allergic and Immunologic Conditions

MotherToBaby supports allergists and immunologists in managing maternal health conditions like asthma, allergies, and atopic dermatitis. We understand the challenges that you face when deciding on treatment courses when your patient is pregnant or breastfeeding. Our resources will help you weigh the risks and benefits to both your patient who is pregnant and their baby as you determine a treatment plan that maximizes disease management and minimizes maternal and fetal/infant risk. 

We are also dedicated to furthering the information and understanding of medication safety in pregnancy through our observational MotherToBaby Pregnancy Studies. We are proud to lead more than half of all Food and Drug Administration (FDA)-mandated pregnancy registries conducted in the U.S., including studies on asthma and atopic dermatitis treatments. MotherToBaby Pregnancy Studies are rigorously designed cohort studies that aim to provide critically needed product safety information – and your patient referrals make all the difference. With your referral, you are helping us generate data that will lead to improved product safety information in pregnancy, thereby providing you and your patients with the evidence you need to make more informed treatment decisions.

In the U.S., 20% of [people who are pregnant] are affected by allergies, especially rhinitis and asthma.

— World Allergy Organization

Explore how we can help you and your pregnant and breastfeeding patients by providing no-cost exposure risk assessments, patient education materials, observational studies to monitor pregnancy outcomes, and more.

Related Studies

  • Asthma
  • COVID-19 Vaccines
  • Coronavirus (COVID-19)
  • Dupixent® (dupilumab)‎
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Fasenra® (benralizumab)
  • Nucala® (mepolizumab) (NO LONGER ENROLLING)

Related Fact Sheets

  • Albuterol
  • Asthma
  • Azelastine
  • Benralizumab (Fasenra®)
  • Cetirizine
  • Chlorpheniramine
  • Diphenhydramine
  • Dupilumab (Dupixent®)
  • Fexofenadine
  • Formoterol (Eformoterol)
  • Inhaled Corticosteroids (ICSs)
  • Loratadine (Claritin®)
  • Montelukast (Singulair®)
  • Oxymetazoline
  • Paternal Exposures
  • Phenylephrine
  • Prednisone | Prednisolone
  • Promethazine (Phenergan®)
  • Pseudoephedrine (Sudafed®)
  • Salmeterol (Serevent Diskus®)
  • Topical Corticosteroids

Exposure Information

We provide no-cost, evidence-based info on exposures during pregnancy or breastfeeding by phone, text, email, and chat.

Contact

Request Materials

We offer free patient education materials and provider resources for our information service and pregnancy studies.

ORDER

Partners

  • Allergy & Asthma Network
  • American Academy of Allergy, Asthma & Immunology
  • Society for Maternal-Fetal Medicine
  • Society for Birth Defects Research & Prevention
  • Patient Education Genius
  • PatientsLikeMe
  • The Mighty

FAQs

Get answers to the most frequently asked questions about our information service and pregnancy studies.

Read

Stay In Touch

Our e-Newsletter brings you the latest information, news, and resources from the experts at MotherToBaby.

Sign Up

Refer a Patient

Need to give your patient a personalized assessment on an exposure risk or connect them to our pregnancy studies?

refer

Footer

           

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Asthma
  • Coronavirus (COVID-19)
  • Crohn’s Disease
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Juvenile Idiopathic Arthritis
  • Multiple Sclerosis
  • Pertussis/Tdap vaccine (“Whooping Cough” vaccine)
  • Psoriasis
  • Psoriatic Arthritis
  • Rheumatoid Arthritis
  • Ulcerative Colitis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists
OTIS Logo

Copyright © 2023 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^